Escondido, CA, United States of America

Eileen Valenzuela Tompkins



 

Average Co-Inventor Count = 7.4

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • San Diego, CA (US) (2005)
  • Escondido, CA (US) (2004 - 2015)

Company Filing History:


Years Active: 2004-2015

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Eileen Valenzuela Tompkins: Innovator in Pharmaceutical Compounds

Introduction

Eileen Valenzuela Tompkins is a notable inventor based in Escondido, CA (US). She has made significant contributions to the field of pharmaceuticals, holding a total of 6 patents. Her work primarily focuses on compounds and their applications in treating various medical conditions.

Latest Patents

Among her latest patents, Eileen has developed compounds and pharmaceutically acceptable salts that are designed to treat diabetes mellitus and its complications, including diabetic retinopathy, nephropathy, and neuropathy. Additionally, her inventions address cancer, ischemia, inflammation, central nervous system disorders, cardiovascular disease, Alzheimer's disease, and dermatological diseases. Another patent involves 3-amido-pyrrolo[3,4-C]pyrazole-5(1H,4H,6H) carbaldehyde derivatives, which also focus on similar therapeutic applications.

Career Highlights

Eileen has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Agouron Pharmaceuticals, Inc. Her experience in these organizations has allowed her to develop innovative solutions that contribute to medical advancements.

Collaborations

Throughout her career, Eileen has collaborated with esteemed colleagues such as Yufeng Hong and Mark Brian Anderson. These partnerships have further enhanced her research and development efforts in the pharmaceutical sector.

Conclusion

Eileen Valenzuela Tompkins is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the treatment of various diseases significantly. Her contributions to the field are noteworthy and continue to inspire innovation in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…